Leukemia regression by vascular disruption and antiangiogenic therapy

Acute myelogenous leukemias (AMLs) and endothelial cells depend on each other for survival and proliferation. Monotherapy antivascular strategies such as targeting vascular endothelial growth factor (VEGF) has limited efficacy in treating AML. Thus, in search of a multitarget antivascular treatment...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Madlambayan, Gerard J., Meacham, Amy M., Hosaka, Koji, Mir, Saad, Jorgensen, Marda, Scott, Edward W., Siemann, Dietmar W., Cogle, Christopher R.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2010
Assuntos:
Myeloid Neoplasia
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2938842/
https://ncbi.nlm.nih.gov/pubmed/20472832
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2009-06-230474
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados